Journal article
Low-Dose vs Standard-Dose Unfractionated Heparin for Percutaneous Coronary Intervention in Acute Coronary Syndromes Treated With Fondaparinux: The FUTURA/OASIS-8 Randomized Trial
Abstract
CONTEXT: The optimal unfractionated heparin regimen for percutaneous coronary intervention (PCI) in patients with non-ST-segment elevation acute coronary syndromes treated with fondaparinux is uncertain.
OBJECTIVE: To compare the safety of 2 unfractionated heparin regimens during PCI in high-risk patients with non-ST-segment elevation acute coronary syndromes initially treated with fondaparinux.
Authors
Steg PG; Jolly SS; Mehta SR; Afzal R; Xavier D; Rupprecht H-J; López-Sendón JL; Budaj A; Diaz R; Avezum A
Journal
JAMA: The Journal of the American Medical Association, Vol. 304, No. 12, pp. 1339–1349
Publisher
American Medical Association (AMA)
Publication Date
September 22, 2010
DOI
10.1001/jama.2010.1320
ISSN
0098-7484